Company / Book Value per Share
Jade Biosciences, Inc. Book Value per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$2.674
FY2024
5-year range
-$55.088 / $14.025
FY2020-FY2024
Trend
-35.7%
vs FY2023
Sector context
#141 of 207
Health Care
What the data says
At $2.674, Jade Biosciences, Inc.'s book value per share ranks #141 of 207 in the Health Care sector. Book Value per Share has declined for 3 consecutive years, from $14.025 in FY2021 to $2.674 in FY2024.
Based on SEC 10-K filings.
$2.674 in FY2024 with a 3-year CAGR of -42.4%.
Declined from $5.179 to $2.674 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -42.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#141 of 207 in Health CareTop 68% of 207This company $2.674 Sector average $208.468
▼
-98.7% below sector average
Key checks
Key Insights
- Jade Biosciences, Inc.'s book value per share has declined for 3 consecutive years.
- 3-year CAGR of -42.4%, indicating a declining trend.
- In FY2024, book value per share decreased 35.7% year-over-year.
- Ranks #141 out of 207 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 6.03 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $2.674 | -35.7% |
| FY2023 | $4.157 | -19.7% |
| FY2022 | $5.179 | -63.1% |
| FY2021 | $14.025 | +125.5% |
| FY2020 | -$55.088 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026